Anuh Pharma Live BSE/NSE | Anuh Pharma Fundamenta data | Anuh Pharma Balance sheet | Anuh Pharma Quarterly Results | Anuh Pharma Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

783.25
31.14
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

825.29
0.88%
4.09

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

5.69
-1.21
8.84

EBITDA CAGR (%)

10 Years
5 Years
3 Years

3.21
-9.16
4.86

PAT CAGR (%)

10 Years
5 Years
3 Years

1.53
-11.12
-4.66

P:E (Median)

8 Years
5 Years
3 Years

19.14
22.04
19.35

P:BV (Average)

8 Years
5 Years
3 Years

3.39
3.39
3.39

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.03
14.33
13.24

Quarterly Results

Standalone Figures in Rs. Crores

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 124 85 46% 72 83 -13% 76 70 8% 74 87 -15%
Expenses 101 77 31% 70 75 -7% 67 64 6% 70 79 -12%
EBITDA 23 8 203% 2 8 -76% 9 6 34% 5 8 -46%
EBIDTM 19% 9% 3% 9% 11% 9% 6% 10%
Other Income 3 1 146% 1 1 32% 1 1 -18% 1 1 -44%
Interest 0 0 462% 1 0 686% 0 0 38% 0 0 200%
Depreciation 4 1 305% 4 1 683% 1 0 148% 1 0 173%
PBT 22 8 179% -2 8 - 8 7 19% 4 10 -54%
Tax 6 2 166% -1 3 - 2 2 23% 1 3 -48%
PAT 17 6 185% -1 5 - 6 5 17% 3 7 -57%
PATM 13% 7% -1% 6% 8% 8% 4% 8%
EPS 3.34 1.17 185% -0.18 1.06 - 1.27 1.08 18% 0.60 1.39 -57%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 346 307 321 238 206 326 284 266 243 226 176 Net Sales Growth 6% -4% 35% 15% -37% 15% 6% 10% 8% 28% Cost Of Goods Sold 250 229 241 180 149 247 220 213 200 188 147 Gross Profit 97 78 79 58 57 79 64 53 43 38 30 GP Margin 28% 26% 25% 25% 28% 24% 22% 20% 18% 17% 17% Total Expenditure 308 284 291 220 183 289 253 242 225 208 159 Power & Fuel Cost - 6 5 4 3 3 3 3 3 3 2 % Of Sales - 2% 1% 2% 1% 1% 1% 1% 1% 1% 1% Employee Cost - 13 10 9 7 7 6 5 4 3 3 % Of Sales - 4% 3% 4% 4% 2% 2% 2% 2% 1% 2% Manufacturing Exp. - 14 15 12 13 15 11 8 7 5 4 % Of Sales - 5% 5% 5% 6% 4% 4% 3% 3% 2% 2% General & Admin Exp. - 2 2 2 2 2 1 2 1 1 1 % Of Sales - 1% 1% 1% 1% 1% 1% 1% 1% 0% 0% Selling & Distn. Exp. - 6 7 6 5 8 6 6 5 4 3 % Of Sales - 2% 2% 2% 2% 3% 2% 2% 2% 2% 2% Miscellaneous Exp. - 13 10 7 4 7 5 5 4 5 3 % Of Sales - 4% 3% 3% 2% 2% 2% 2% 2% 2% 1% EBITDA 38 23 30 18 23 38 31 24 18 18 17 EBITDA Margin 11% 8% 9% 8% 11% 12% 11% 9% 7% 8% 10% Other Income 6 4 5 7 8 4 5 4 2 3 3 Interest 1 1 1 0 1 1 1 1 1 1 1 Depreciation 10 7 2 2 2 2 3 2 2 1 1 PBT 33 19 32 23 28 38 32 25 18 18 18 Tax 8 5 9 7 8 12 10 8 5 5 5 Tax Rate 25% 25% 28% 29% 27% 32% 31% 31% 29% 29% 30% PAT 25 14 23 17 20 26 22 18 13 13 12 PAT before Minority Interest 25 14 23 17 20 26 22 18 13 13 12 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 7% 5% 7% 7% 10% 8% 8% 7% 5% 6% 7% PAT Growth 7% -39% 42% -18% -22% 17% 25% 40% -2% 5% EPS 5.02 2.86 4.66 3.30 4.00 5.15 4.39 3.51 2.50 2.56 2.45

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

346

307

321

238

206

326

284

266

243

226

176

Net Sales Growth

-4%

35%

15%

-37%

15%

10%

28%

Cost Of Goods Sold

250

229

241

180

149

247

220

213

200

188

147

Gross Profit

GP Margin

28%

26%

25%

28%

24%

22%

20%

18%

17%

Total Expenditure

308

284

291

220

183

289

253

242

225

208

159

Power & Fuel Cost

% Of Sales

Employee Cost

% Of Sales

Manufacturing Exp.

% Of Sales

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

% Of Sales

EBITDA

EBITDA Margin

11%

12%

11%

10%

Other Income

Interest

Depreciation

PBT

Tax

Tax Rate

25%

28%

29%

27%

32%

31%

29%

30%

PAT

PAT before Minority Interest

Minority Interest

PAT Margin

10%

PAT Growth

-39%

42%

-18%

-22%

17%

25%

40%

-2%

EPS

5.02

2.86

4.66

3.30

4.00

5.15

4.39

3.51

2.50

2.56

2.45

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 162 165 150 141 119 101 86 76 69 61 Share Capital 13 13 13 13 13 4 4 4 4 4 Total Reserves 150 152 137 128 107 97 82 71 65 57 Non-Current Liabilities 1 0 0 0 0 0 0 0 0 0 Secured Loans 0 0 0 0 0 0 0 0 0 0 Unsecured Loans 0 0 0 0 0 0 0 0 0 0 Long Term Provisions 1 1 1 1 1 1 0 0 0 0 Current Liabilities 163 75 59 47 72 67 77 60 50 62 Trade Payables 105 59 52 42 52 48 60 47 29 22 Other Current Liabilities 13 11 3 4 3 2 2 1 3 10 Short Term Borrowings 45 4 2 0 2 0 0 1 1 7 Short Term Provisions 0 0 1 1 15 17 15 11 16 23 Total Liabilities 326 239 208 187 191 168 163 136 119 124 Net Block 84 21 17 17 18 9 12 10 8 8 Gross Block 96 27 20 19 33 23 24 20 16 16 Accumulated Depreciation 12 5 4 2 15 13 12 10 8 8 Non Current Assets 103 87 54 50 40 24 22 20 37 24 Capital Work in Progress 0 34 6 0 0 0 0 3 3 2 Non Current Investment 14 30 31 31 21 13 8 6 25 14 Long Term Loans & Adv. 3 2 1 1 1 1 1 1 1 1 Other Non Current Assets 3 0 0 0 0 0 0 0 0 0 Current Assets 223 152 154 138 151 144 142 117 82 99 Current Investments 66 9 36 39 22 29 19 14 8 18 Inventories 61 43 32 30 24 16 19 24 13 17 Sundry Debtors 81 75 71 57 75 68 75 54 39 25 Cash & Bank 3 11 8 6 13 14 15 13 7 9 Other Current Assets 12 11 7 2 17 16 13 11 16 31 Short Term Loans & Adv. 5 3 1 4 15 14 12 10 15 30 Net Current Assets 60 77 96 91 79 77 65 57 33 37 Total Assets 326 239 208 187 191 168 163 136 119 124

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

162

165

150

141

119

101

Share Capital

Total Reserves

150

152

137

128

107

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

163

Trade Payables

105

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

326

239

208

187

191

168

163

136

119

124

Net Block

Gross Block

Accumulated Depreciation

Non Current Assets

103

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

223

152

154

138

151

144

142

117

Current Investments

Inventories

Sundry Debtors

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

Total Assets

326

239

208

187

191

168

163

136

119

124

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 49 7 2 26 16 19 15 2 9 -1 PBT 19 32 23 28 38 32 25 18 18 18 Adjustment 8 -2 -2 -5 -1 -1 -2 0 -1 -1 Changes in Working Capital 27 -13 -13 11 -8 -1 -3 -11 -2 -11 Cash after chg. in Working capital 54 17 9 34 29 30 21 7 15 5 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -5 -10 -7 -8 -13 -11 -6 -5 -6 -6 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -77 3 2 -20 -5 -12 -5 4 2 -6 Net Fixed Assets -36 -34 -7 14 -11 1 -1 -4 -1 -2 Net Investments -41 28 4 -27 0 -16 -7 13 -1 -6 Others 0 9 5 -7 6 3 4 -5 5 2 Cash from Financing Activity 22 -7 -5 -4 -9 -8 -8 -6 -11 4 Net Cash Inflow / Outflow -5 3 -1 2 2 -1 2 0 0 -3 Opening Cash & Equivalents 7 4 5 3 1 2 0 0 0 3 Closing Cash & Equivalent 2 7 4 5 3 1 2 0 0 0

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

-1

PBT

Adjustment

-2

-5

-1

-2

-1

Changes in Working Capital

-13

-8

-1

-3

-11

-2

-11

Cash after chg. in Working capital

Interest Paid

Tax Paid

-5

-10

-7

-8

-13

-11

-6

-5

-6

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-77

-20

-5

-12

-5

-6

Net Fixed Assets

-36

-34

-7

-11

-1

-4

-1

-2

Net Investments

-41

-27

-16

-7

-1

-6

Others

-7

-5

Cash from Financing Activity

-7

-5

-4

-9

-8

-6

-11

Net Cash Inflow / Outflow

-5

-1

-3

Opening Cash & Equivalents

Closing Cash & Equivalent

Financial Ratios

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 32 33 60 56 48 40 34 30 28 24 ROA 5% 10% 8% 11% 14% 13% 12% 10% 11% 10% ROE 9% 15% 11% 15% 23% 24% 22% 17% 20% 21% ROCE 11% 21% 16% 22% 35% 35% 33% 26% 28% 30% Fixed Asset Turnover 5.17 13.71 12.23 8.23 12.19 13.02 12.95 14.39 15.20 12.91 Receivable days 89 82 96 110 76 87 83 65 49 57 Inventory Days 60 42 46 45 21 22 28 25 22 26 Payable days 111 71 80 97 64 80 84 62 46 69 Cash Conversion Cycle 38 54 62 58 33 29 26 29 26 14 Total Debt/Equity 0.27 0.03 0.02 0.00 0.02 0.00 0.00 0.01 0.02 0.11 Interest Cover 16 55 53 39 45 35 22 18 16 19

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

ROA

10%

11%

14%

13%

12%

10%

11%

10%

ROE

15%

11%

15%

23%

24%

22%

17%

20%

21%

ROCE

11%

21%

16%

22%

35%

33%

26%

28%

30%

Fixed Asset Turnover

5.17

13.71

12.23

8.23

12.19

13.02

12.95

14.39

15.20

12.91

Receivable days

110

Inventory Days

Payable days

111

Cash Conversion Cycle

Total Debt/Equity

0.27

0.03

0.02

0.00

0.02

0.00

0.01

0.02

0.11

Interest Cover

Anuh Pharma Ltd.

Pharmaceuticals & Drugs - API

BSE: 506260 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Anuh Pharma Ltd.

Pharmaceuticals & Drugs - API

BSE: 506260 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update